Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in radiotherapy.

R A Abrams1

  • 1Johns Hopkins Hospital, Division of Radiation Oncology, Baltimore, MD 21287.

Current Opinion in Oncology
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.

British journal of cancer·2017
Same author

Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.

International journal of radiation oncology, biology, physics·2003
Same author

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Advancements in radiation oncology enhance treatment efficacy and safety. New techniques and agents improve tumor control and patient outcomes, particularly in combined chemotherapy and radiotherapy approaches.

Area of Science:

  • Oncology
  • Radiotherapy
  • Radiobiology

Background:

  • Radiation oncology is rapidly evolving with growing radiobiologic understanding.
  • New fractionation regimens and high-dose-rate brachytherapy are being integrated into clinical practice.
  • Emerging agents and technologies promise to refine treatment strategies.

Purpose of the Study:

  • To explore advancements in radiation oncology.
  • To highlight new therapeutic agents and technologies.
  • To discuss the integration of novel approaches in cancer treatment.

Main Methods:

  • Investigating altered fractionation regimens.
  • Implementing high-dose-rate brachytherapy.
  • Utilizing novel agents like SR 4233 for tumor hypoxia.

Related Experiment Videos

  • Employing 3D treatment planning for precise radiation delivery.
  • Studying drug-irradiation and cytokine-irradiation interactions.

    • Main Results:

    • Improved understanding of radiobiology facilitates safer clinical integration of advanced techniques.
    • SR 4233 shows potential to revolutionize treatment for tumor hypoxia.
    • 3D treatment planning allows for precise radiation delivery, minimizing normal tissue toxicity.
    • Combined chemotherapy and radiotherapy demonstrate significant improvements in esophageal and laryngeal cancer management.
    • Enhanced local and regional tumor control is increasingly recognized as critical for patient outcomes.

    Conclusions:

    • Advances in radiation oncology, including novel agents and precise planning, are improving cancer treatment.
    • Combined modality treatments show promise for better disease management and patient survival.
    • The growing understanding of radiobiology and treatment interactions is key to future progress in oncology.